IP Library › Assignment 033223/0977
Patent Assignment
Reel/Frame 033223/0977

Assignment of Assignor's Interest

Recorded: 2014-07-01 Pages: 3
Assignor
THOMPSON, JAMES D.
Executed: 2014-07-01
Assignee
QUARK PHARMACEUTICALS, INC.
6501 DUMBARTON CIRCLE, FREMONT, CALIFORNIA, 94555
Covered Property (1)
A Double-Stranded Oligonucleotide Compound for Down-Regulating the Expression of CASP2 Gene
Patent: 8,765,931 →
Application: 13/062,161 →
Publication: US 2011/0229557
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 17, 2011
From: FEINSTEIN, ELENA; ALPERT, EVGENIA; METT, IGOR; BAR-ILAN, AMIR
To: QUARK PHARMACEUTICALS, INC.
Reel/Frame 026294/0869 →
Patent Security Agreement Aug 4, 2011
From: QUARK PHARMACEUTICALS, INC.; Q.B.I. ENTERPRISES LTD.
To: NITTO DENKO CORPORATION
Reel/Frame 026699/0495 →
Assignment of Assignor's Interest Oct 19, 2023
From: QUARK PHARMACEUTICALS, INC.
To: SUZHOU RIBO LIFE SCIENCE CO., LTD.
Reel/Frame 065280/0562 →